These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 29866129

  • 1. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    Friedrich D, Marschall HU, Lammert F.
    BMC Gastroenterol; 2018 Jun 04; 18(1):76. PubMed ID: 29866129
    [Abstract] [Full Text] [Related]

  • 2. Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.
    Appleby RN, Moghul I, Khan S, Yee M, Manousou P, Neal TD, Walters JRF.
    PLoS One; 2019 Jun 04; 14(1):e0211348. PubMed ID: 30682184
    [Abstract] [Full Text] [Related]

  • 3. Dynamic pattern of postprandial bile acids in paediatric non-alcoholic fatty liver disease.
    Huang J, Lin H, Liu AN, Wu W, Alisi A, Loomba R, Xu C, Xiang W, Shao J, Dong G, Zheng MH, Fu J, Ni Y.
    Liver Int; 2024 Oct 04; 44(10):2793-2806. PubMed ID: 39082260
    [Abstract] [Full Text] [Related]

  • 4. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.
    Schreuder TC, Marsman HA, Lenicek M, van Werven JR, Nederveen AJ, Jansen PL, Schaap FG.
    Am J Physiol Gastrointest Liver Physiol; 2010 Mar 04; 298(3):G440-5. PubMed ID: 20093562
    [Abstract] [Full Text] [Related]

  • 5. An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy Volunteers.
    Al-Khaifi A, Rudling M, Angelin B.
    Gastroenterology; 2018 Oct 04; 155(4):1012-1016. PubMed ID: 29928896
    [Abstract] [Full Text] [Related]

  • 6. Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    Mouzaki M, Wang AY, Bandsma R, Comelli EM, Arendt BM, Zhang L, Fung S, Fischer SE, McGilvray IG, Allard JP.
    PLoS One; 2016 Oct 04; 11(5):e0151829. PubMed ID: 27203081
    [Abstract] [Full Text] [Related]

  • 7. Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women.
    Mercer KE, Maurer A, Pack LM, Ono-Moore K, Spray BJ, Campbell C, Chandler CJ, Burnett D, Souza E, Casazza G, Keim N, Newman J, Hunter G, Fernadez J, Garvey WT, Harper ME, Hoppel C, Adams SH, Thyfault J.
    Am J Physiol Endocrinol Metab; 2021 May 01; 320(5):E864-E873. PubMed ID: 33645254
    [Abstract] [Full Text] [Related]

  • 8. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.
    Pattni SS, Brydon WG, Dew T, Johnston IM, Nolan JD, Srinivas M, Basumani P, Bardhan KD, Walters JR.
    Aliment Pharmacol Ther; 2013 Oct 01; 38(8):967-76. PubMed ID: 23981126
    [Abstract] [Full Text] [Related]

  • 9. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.
    Zweers SJ, de Vries EM, Lenicek M, Tolenaars D, de Waart DR, Koelfat KV, Groen AK, Olde Damink SW, Beuers U, Ponsioen C, Jansen PL, Schaap FG.
    Hepatol Int; 2017 Jan 01; 11(1):132-140. PubMed ID: 27696157
    [Abstract] [Full Text] [Related]

  • 10. Acute Changes of Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.
    Chen Y, Lu J, Nemati R, Plank LD, Murphy R.
    Obes Surg; 2019 Nov 01; 29(11):3605-3621. PubMed ID: 31273649
    [Abstract] [Full Text] [Related]

  • 11. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.
    Lundåsen T, Gälman C, Angelin B, Rudling M.
    J Intern Med; 2006 Dec 01; 260(6):530-6. PubMed ID: 17116003
    [Abstract] [Full Text] [Related]

  • 12. A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents.
    Wojcik M, Janus D, Dolezal-Oltarzewska K, Kalicka-Kasperczyk A, Poplawska K, Drozdz D, Sztefko K, Starzyk JB.
    J Pediatr Endocrinol Metab; 2012 Dec 01; 25(11-12):1089-93. PubMed ID: 23329754
    [Abstract] [Full Text] [Related]

  • 13. Chenodeoxycholic acid stimulated fibroblast growth factor 19 response - a potential biochemical test for bile acid diarrhoea.
    Borup C, Wildt S, Rumessen JJ, Bouchelouche PN, Graff J, Damgaard M, McQuitty C, Rainteau D, Munck LK.
    Aliment Pharmacol Ther; 2017 Jun 01; 45(11):1433-1442. PubMed ID: 28378364
    [Abstract] [Full Text] [Related]

  • 14. Effects of supplemented isoenergetic diets varying in cereal fiber and protein content on the bile acid metabolic signature and relation to insulin resistance.
    Weickert MO, Hattersley JG, Kyrou I, Arafat AM, Rudovich N, Roden M, Nowotny P, von Loeffelholz C, Matysik S, Schmitz G, Pfeiffer AFH.
    Nutr Diabetes; 2018 Mar 07; 8(1):11. PubMed ID: 29549243
    [Abstract] [Full Text] [Related]

  • 15. Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19.
    Barrera F, Azócar L, Molina H, Schalper KA, Ocares M, Liberona J, Villarroel L, Pimentel F, Pérez-Ayuso RM, Nervi F, Groen AK, Miquel JF.
    Ann Hepatol; 2015 Mar 07; 14(5):710-21. PubMed ID: 26256900
    [Abstract] [Full Text] [Related]

  • 16. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.
    Walters JR, Tasleem AM, Omer OS, Brydon WG, Dew T, le Roux CW.
    Clin Gastroenterol Hepatol; 2009 Nov 07; 7(11):1189-94. PubMed ID: 19426836
    [Abstract] [Full Text] [Related]

  • 17. Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects.
    Legry V, Francque S, Haas JT, Verrijken A, Caron S, Chávez-Talavera O, Vallez E, Vonghia L, Dirinck E, Verhaegen A, Kouach M, Lestavel S, Lefebvre P, Van Gaal L, Tailleux A, Paumelle R, Staels B.
    J Clin Endocrinol Metab; 2017 Oct 01; 102(10):3783-3794. PubMed ID: 28938455
    [Abstract] [Full Text] [Related]

  • 18. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
    Hernandez GV, Smith VA, Melnyk M, Burd MA, Sprayberry KA, Edwards MS, Peterson DG, Bennet DC, Fanter RK, Columbus DA, Steibel JP, Glanz H, Immoos C, Rice MS, Santiago-Rodriguez TM, Blank J, VanderKelen JJ, Kitts CL, Piccolo BD, La Frano MR, Burrin DG, Maj M, Manjarin R.
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar 01; 318(3):G582-G609. PubMed ID: 32003601
    [Abstract] [Full Text] [Related]

  • 19. Obeticholic acid may increase the risk of gallstone formation in susceptible patients.
    Al-Dury S, Wahlström A, Panzitt K, Thorell A, Ståhlman M, Trauner M, Fickert P, Bäckhed F, Fändriks L, Wagner M, Marschall HU.
    J Hepatol; 2019 Nov 01; 71(5):986-991. PubMed ID: 31254596
    [Abstract] [Full Text] [Related]

  • 20. Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.
    Battat R, Duijvestein M, Vande Casteele N, Singh S, Dulai PS, Valasek MA, Mimms L, McFarland J, Hester KD, Renshaw M, Jain A, Sandborn WJ, Boland BS.
    Clin Gastroenterol Hepatol; 2019 Dec 01; 17(13):2722-2730.e4. PubMed ID: 30448597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.